Post by
floatinketucky on Dec 17, 2021 9:41am
Theralase CEO has shareholder value in mind.
"I am honored to return as the Interim CEO for the Company, as the Company realigns its executive management team to focus on the Company’s primary objective of commercialization of its ACT technology, which, if successful, will ultimately deliver shareholder value." Dr Arkady Mandel Interim CEO & CSO, Theralase®
Comment by
floatinketucky on Dec 23, 2021 8:17am
They seem to be moving in the right direction.